Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Significant Decline in Short Interest

by · The Markets Daily

Aethlon Medical, Inc. (NASDAQ:AEMD – Get Free Report) was the target of a large decrease in short interest in August. As of August 14th, there was short interest totaling 65,075 shares, a decrease of 71.9% from the July 30th total of 231,654 shares. Based on an average daily trading volume, of 65,331 shares, the short-interest ratio is presently 1.0 days. Approximately 9.2% of the shares of the stock are short sold.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. HC Wainwright reissued a “neutral” rating and issued a $1.50 target price on shares of Aethlon Medical in a report on Tuesday, August 18th. Wall Street Zen raised shares of Aethlon Medical to a “sell” rating in a research note on Saturday, August 8th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Aethlon Medical in a research report on Friday, July 17th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Reduce” and an average target price of $1.50.

Check Out Our Latest Stock Report on Aethlon Medical

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Aethlon Medical stock. Citadel Advisors LLC acquired a new position in shares of Aethlon Medical, Inc. (NASDAQ:AEMD – Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 95,084 shares of the medical equipment provider’s stock, valued at approximately $71,000. Citadel Advisors LLC owned 36.57% of Aethlon Medical as of its most recent SEC filing. Institutional investors and hedge funds own 1.99% of the company’s stock.

Aethlon Medical Price Performance

NASDAQ AEMD traded up $0.32 during trading on Friday, reaching $2.49. 44,996,970 shares of the company’s stock were exchanged, compared to its average volume of 894,248. Aethlon Medical has a fifty-two week low of $2.17 and a fifty-two week high of $105.00. The business has a 50 day moving average price of $3.39 and a 200-day moving average price of $8.09. The stock has a market capitalization of $1.77 million, a P/E ratio of -0.07 and a beta of 1.41.

Aethlon Medical (NASDAQ:AEMD – Get Free Report) last issued its quarterly earnings data on Thursday, August 13th. The medical equipment provider reported ($4.02) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($3.92) by ($0.10). On average, analysts forecast that Aethlon Medical will post -5.74 earnings per share for the current year.

Aethlon Medical Company Profile

(Get Free Report)

Aethlon Medical, Inc (NASDAQ: AEMD) is a clinical‐stage biotechnology company focused on developing novel immunotherapeutic medical devices to address life‐threatening diseases. The company’s lead product candidate, the Hemopurifier®, is an extracorporeal affinity device designed to remove circulating viruses and immunosuppressive exosomes from the bloodstream. By targeting glycosylated pathogens and exosomes, Aethlon aims to restore immune function and improve patient outcomes in oncology and infectious disease settings.

The Hemopurifier platform leverages proprietary lectin affinity technology to selectively bind and eliminate harmful particles without depleting healthy blood components.

Recommended Stories